Mesothelioma | Mesothelioma news | Breaking lung cancer news | Mesothelioma

News

Advertisers:

Gemzar�/Platinol� Superior to VePesid�/Platinol� in Non-Small ...

...Non-small cell NSCLC is named for the type of cell within the lung where the cancer originated.In locally advanced Chemotherapy remains the cornerstone of treatment for locally advanced NSCLC.

Long-term survival, however, is unfavorable for patients with this disease.

Researchers continue to evaluate novel therapeutic options, including different chemotherapy combinations.Paclitaxel plus carboplatin is one of the most commonly used chemotherapy regimens in the treatment of NSCLC in the U.S.

and Europe.

Gemzar is currently approved for use with cisplatin as initial therapy in advanced NSCLC, as well as treatment of pancreatic cancer and in combination with paclitaxel for the treatment of recurrent, advanced breast cancer.Researchers from South Korea recently conducted a clinical trial to compare treatment with Gemzar plus cisplatin (GP) to etoposide plus cisplatin (EP) in patients with locally advanced NSCLC.

This trial included 83 patients from nine medical centers in Korea who were treated between 2000 and 2001.GP provided superior results to EP in this group of patients:Anticancer responses were achieved in 52.6% of patients treated with GP compared with only 19.4% of patients treated with EP.Overall ...